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Abstract
Background: Abdominoperineal excision is performed in patients with locally advanced, low rectal carcinoma.
Reconstruction of the dorsal vagina and perineum using the vertical rectus abdominis myocutaneous flap following
extensive surgery results in favorable surgical outcome and quality of life. However, the rectus abdominis muscle, as
part of the anterior abdominal wall, may develop fibrous lesions also as a transplant.
Case presentation: A 39-year-old female patient with low rectal cancer and extensive colorectal polyposis was treated
with neoadjuvant chemoradiotherapy followed by colectomy and abdominoperineal excision with resection of the
dorsal vaginal wall and subsequent reconstruction of the perineum using the vertical rectus abdominis myocutaneous
flap. At the 6-month follow-up, a suspected 2 × 2 cm tumor recurrence was detected in the transposed tissue and was
subsequently surgically removed. Histologic examination concluded with fibromatosis. Genetic testing revealed a known
disease-causing mutation in the adenomatous polyposis coli gene, confirming the diagnosis of familial adenomatous
polyposis.
Conclusions: Fibromatosis may affect the anterior abdominal wall, that is the rectus abdominis muscle, at the primary
site or may develop in the muscle after its transposition into the perineum at pelvic reconstruction. Fibromatosis in the
muscle flap after pelvic reconstruction may present a difficult diagnostic challenge for the multidisciplinary team.
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Background
For low rectal cancer, abdominoperineal excision (APE) is
usually the procedure of choice, and in locally advanced
cases, the majority of patients require extralevatoric exci-
sion to achieve adequate circumferential resection mar-
gins [1]. Tumor involvement of the posterior vaginal wall
implicates not only the necessity for resection but also the
transposition of tissue to reconstruct the vaginal continu-
ity and promote wound healing [2, 3]. Commonly, a
vertical rectus abdominis myocutaneous (VRAM) flap is
used for this purpose, as it has been shown to decrease
wound complications after surgery [4, 5].
Case presentation
A 39-year-old, healthy, non-smoking female patient with
no family history of cancer was referred on suspicion of
rectal cancer. Digital rectal examination and subsequent
rigid proctoscopy revealed a low rectal tumor and mul-
tiple polyps in the rectum. Subsequent colonoscopy
showed extensive polyposis of the entire colon. The
tumor biopsy confirmed the presence of a rectal adeno-
carcinoma, while dysplastic changes were found in the
polyp biopsies. No distant metastases were detected on
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the thoracoabdominal computed tomography (CT) scan,
and baseline carcinoembryonic antigen (CEA) was 8 μg/L.
Pelvic magnetic resonance imaging (MRI) revealed a lo-
cally advanced rectal cancer with extra-mesorectal growth
into the rectovaginal septum and the lower posterior vagi-
nal wall as well as a suspected growth into the anterior
aspect of the coccygeal bone with multiple suspected ma-
lignant lymph nodes within the mesorectum (T4N2).
Upon evaluation by our multidisciplinary team (MDT),
she was scheduled for neoadjuvant chemoradiotherapy
(CRT) followed by surgery. Neoadjuvant treatment was
given as CT planned radiotherapy (daily 2-Gy fractions,
5 days per week; the initial 23 fractions to the macro-
scopic tumor and areas at risk, and the two final fractions
adapted to the macroscopic tumor) with concomitant cap-
ecitabine (825 mg/m2) on days of RT. The response evalu-
ation showed excellent tumor volume response, but with
similar organ involvement as at baseline, and she pro-
ceeded to surgery 8 weeks after CRT completion. Surgery
involved total colectomy, APE with resection of the pos-
terior vaginal wall and coccygeal bone with subsequent
reconstruction of the perineum with right-sided VRAM
flap, and a terminal ileostomy. After an uneventful recov-
ery, she was discharged 15 days postoperatively. Histologic
examination of the specimen showed a 35-mm large ade-
nosquamous carcinoma removed with free resection mar-
gins and metastasis in one of four local lymph nodes
(pT2N1). In addition, multiple dysplastic adenomas were
present in the entire colon.
At the routine follow-up 6 months postoperatively, clin-
ical examination revealed a 2 × 2 cm tumor located in the
muscle tissue of the VRAM flap, and an early local recur-
rence was suspected. Pelvic MRI showed a 10 × 16 mm
rich vascularized and cell dense lesion corresponding to
the clinically detected tumor (Fig. 1). No other patho-
logical findings were made on CT or MRI, and CEA was
1 μg/L. The lesion was surgically excised with a wide local
resection of the tumor. Interestingly, histologic examin-
ation of the removed lesion described a mass composed of
fatty tissue, fibrocytes, and fibroblasts arranged in broad,
sweeping fascicles infiltrating the adjacent striated
muscle tissue. No dysplasia was observed, but mitoses
were present. Immunohistochemistry showed positive
staining for β-catenin (ABCAM, Cambridge, USA), and
the tumor was diagnosed as a fibromatosis (Fig. 2). The
medical geneticists suspected familial adenomatous polyp-
osis (FAP), and testing of the APC gene, revealed a known
disease-causing mutation c.3317dupG (p.Ala1107Serfs*12),
confirming this diagnosis.
Conclusions
Deep fibromatosis (desmoid tumor) is a benign, myofi-
broblastic proliferation that rarely occurs in the general
population but frequently in one of the hereditary cancer
Fig. 1 Transversal MR images (a–c) and hematoxylin and eosin stained tumor section (d); localization outlined in purple squares. a T2-weighted
image. b Dynamic contrast enhanced parameter map (KTRANS). c Heavily diffusion weighted image (b1500). MRI-indicated and rich vascularization
(b) and high cellularity (c)
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predisposition conditions known as FAP or a variant of
FAP called Gardner syndrome [6, 7]. Nearly all deep
fibromatoses have somatic β-catenin or APC gene muta-
tions leading to intranuclear accumulation of β-catenin
[8]. Nuclear detection of β-catenin by immunohisto-
chemistry is reported in 80–98 % of cases and is used in
diagnostics [9, 10]. Desmoid tumors in FAP are typically
associated with mutations in the APC gene located
downstream of codon 1400 [11]. However, the genotype-
phenotype association is not absolute, as in this case,
where the mutation is approximately 300 codons up-
stream of codon 1400. The clinical presentation of fibro-
matosis is variable, depending on the location and the
extent of the lesion. Desmoids may occur in any musculo-
aponeurotic tissue structures of the body as well as within
the abdominal cavity. Extra-abdominal fibromatoses arise
typically from the rectus or internal oblique muscles and
fascia predominantly in young women. Previous surgery
and trauma sites and irradiated tissues may also be a char-
acteristic place of desmoid expansion [12, 13].
Taking into consideration all of these factors, our pa-
tient was at high risk of developing fibromatosis. How-
ever, as the standard follow-up procedure for patients
undergoing rectal cancer treatment is to focus on early
detection of recurrence and metastasis, and furthermore
considering the patient’s primary diagnosis, the MRI
findings, the lesion site, and its rapid development, the
initial conclusion was local recurrence. Fibromatosis as a
differential diagnosis was thus not considered, and the
MDT opted for direct surgical removal, as the lesion’s
location and size were found to be appropriate for primary
surgical removal. The use of PET-CT was discussed, but
high-quality CT and MRI analysis did not reveal additional
suspected malignant lesions and were considered suffi-
cient for making treatment decisions. The histological
examination, however, revealed fibromatosis in the VRAM
flap in the perineum instead of the expected recurrence. It
is noteworthy that no sign of fibromatosis in the abdom-
inal rectus muscle was found on the CT prior to the pri-
mary surgery.
Currently, the universal approach to management of
desmoid tumors (both abdominal and extra-abdominal)
favors the “watch and wait” approach rather than surgi-
cal removal. This is based on the observation that size
stabilization or spontaneous regression may occur
while surgery in itself may trigger the growth of new
lesions [14, 15].
In this case, no histological evidence (biopsy) was avail-
able to support such a decision, nor was the genetic evalu-
ation implemented. The lesion was considered to be a
suspected local relapse without distant metastases at the
time of diagnosis and was dealt with according to national
guidelines for treatment of recurrent rectal cancer.
In this case, fibromatosis in transposed rectus abdom-
inis muscle tissue imitated a rectal cancer recurrence.
Although rare, but with pelvic reconstructive surgery
becoming more frequent, this may be a relevant differ-
ential diagnosis for the MDT to consider, particularly in
patients with FAP.
Consent
Written informed consent was obtained from the patient
for publication of the case report and any accompanying
images. A copy of the written consent is available for re-
view at the editor of this journal.
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Fig. 2 Histologic high power views of the resected tumor. a Hematoxylin and eosin staining. b ß-catenin immunohistochemical staining
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